Daprodustat vs epoetin for anemia in kidney disease
Treatments studied
Part of Blood & lymphatic, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study compares two anemia medicines for people with chronic kidney disease (CKD) who are not on dialysis. It aims to find a more convenient pill option (daprodustat) versus a commonly used injection (epoetin alfa).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 65 years old.
- You have chronic kidney disease (CKD) stage 3, 4, or 5 and are not on dialysis.
- Your hemoglobin (oxygen-carrying protein in red blood cells) is between 8.0 and 10 g/dL.
- Your iron levels (ferritin and transferrin saturation) meet certain minimums at screening.
- You have not had recent major bleeding, surgery, or blood transfusion in the last 4 weeks.
- You do not have uncontrolled high blood pressure, recent heart attack/stroke, or active cancer or infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new pill, vadadustat, for people on dialysis who have anemia. It looks at whether switching from the current treatment (Epogen) to this pill is safe and works well.
This study is collecting information from people with chronic kidney disease and anemia who are taking a medication called daprodustat. The goal is to learn more about how well it works and how it affects patients in real life.
This study tests an experimental medicine for anemia in people with kidney disease who are on dialysis. It aims to see if it can help raise blood counts safely compared to standard treatments.
This study tests a new drug called Efepoetin Alfa to treat anemia in people with chronic kidney disease who are on dialysis. The goal is to see if it can safely raise red blood cell levels and reduce the need for other anemia treatments.
This study compares two similar medicines used to treat anemia (low red blood cells) in people with advanced kidney disease who are on dialysis. The goal is to see if both work equally well.
This trial tests enarodustat, a pill for anemia, in people with chronic kidney disease who are not on dialysis. It aims to see if it can safely raise hemoglobin levels.
Hear when a new Chronic Kidney Disease (Stages 3b-5) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.